A modest, replicated lift in how you're perceived, paid for almost entirely by carrying yourself like someone who smells good. Cheap on a per-day basis, no daily effort, no special skill — and a bottle lasts one to three years. The catch is real but boring: a third of the people around you can't tolerate it well, the old bottle on your dresser becomes a skin-allergen risk past the two-year mark, and "natural" doesn't mean safer. Wear it deliberately; don't soak in it.
The interesting part isn't what fragrance does to a person standing across the room from you — it's what it does to you. The same morning you spray something you like, you make eye contact a beat longer, you stand a fraction taller in the lift, you don't look at your shoes during the small-talk. Raters watching short clips with no sound and no smell still pick those days out. That's the mechanism that earns most of the social-perception effect. The scent itself, drifting off your skin at body temperature, is the secondary channel.
Two things happen at once when you smell something. The molecules dock onto receptors in your nose and the signal lands in your amygdala and your memory centres before your thinking-brain even gets a copy — which is why a stranger's perfume on the train can drop you back into a relationship from a decade ago in under a second. And the same skin chemistry that releases the scent over six or eight hours also slowly pushes the volatile ingredients through the surrounding air, where the people near you breathe it in at roughly the dose the formulator was aiming for at arm's length — and at several times that dose if they're sitting next to you in a car.
Does it actually work
The social-perception effect is the one piece of fragrance that has been pinned down properly. The cleanest design is the silent-video study: put a fragrance on one group of people, a placebo on another, film a short clip of each in conversation, mute the audio, and have neutral raters score them. The raters can't hear them, can't smell them, and don't know which group anyone's in. The fragranced group still scores higher on attractiveness and confidence.
The effect is real and replicated but it's not large. Honest framing: a noticeable nudge on average, not a transformation — somewhere between "well-rested" and "good haircut" in size. Mood effects on the wearer are smaller still and run mostly through your own associations — the scent your grandmother wore lands differently than the same molecule unfamiliar to you. Don't expect a fragrance to fix your day; expect it to compound what your day is already doing.
The cost you don't pay — someone else does
Roughly one in three of the people you share an office, a lift, or a train carriage with reacts badly to fragrance worn by others. That isn't an opinion or a preference; it's a population number that's been replicated across four countries.
For migraineurs the number is starker. A case-control study put two hundred migraine sufferers and two hundred tension-headache controls in front of common odorants; 70% of the migraine group got a headache within about twenty-five minutes, and not one of the tension-headache controls did. Perfume was the trigger in three-quarters of those attacks, ahead of paint, gasoline, and bleach Silva-Néto et al. 2014.
The wearer doesn't notice any of this. Your nose adapts to your own scent within minutes — you stop registering the cloud you're inside, while the person sitting next to you registers nothing else. The colleague who keeps "stepping out for some air" during your meetings, the friend who quietly drops the carpool, the receptionist who develops a tension in her jaw when you walk in: this is what those signals look like at the population level. If you don't ask, you don't find out.
How to wear it
Two to four sprays for an eau de parfum, four to six for an eau de toilette. Aim at the warm spots — the inside of your wrists, the side of your neck, the centre of your chest — because the surface arteries there sit at 34–36 °C and that warmth volatilises the top-notes into the air around you over the next hour. Then leave it alone. Don't rub your wrists together; the shearing motion breaks up the lighter notes and shortens the wear.
Concentration goes the opposite direction of what most people guess. A higher number on the bottle — parfum over eau de parfum over eau de toilette — means more oil and less alcohol, so the scent stays on the skin longer but projects less far in the first hour. A heavy parfum on a date with one other person is the right move; the same parfum on a packed flight is not.
When not to wear it
What most people get wrong
"Natural means safer." The two most common fragrance ingredients in the EU market are limonene (the smell of orange peel) and linalool (the smell of lavender) — both natural terpenes, both present in about a quarter of all cosmetic products. They start out as weak allergens, but once a bottle has been opened to the air for months they oxidise into hydroperoxides that are some of the strongest contact sensitisers known. Patch-test data from nearly 6,000 dermatitis patients shows about 7% react to oxidised linalool and 5% to oxidised limonene, with the rate trending upward year over year Sukakul et al. 2022. "Natural fragrance" is the modern-day allergy story, not the synthetic-musk panic of twenty years ago.
"Higher concentration means stronger projection." The opposite. More oil and less alcohol means the scent stays close to your skin longer; less oil and more alcohol means it flashes into the air faster. Parfum stays on your wrist longer than EDT — and people more than a foot away from you will smell the EDT first.
"If I can still smell mine, it's still projecting." Your nose has adapted to a familiar smell within minutes — it's a basic feature of olfactory receptors. The cloud you can no longer smell is the cloud everyone else still walks into.
"Phthalates were banned, so my perfume is fine now." Six of the seven phthalates classified as reproductive toxins are restricted in EU cosmetics. The seventh — diethyl phthalate (DEP) — is the one actually used in fragrance as a fixative, and it remains permitted by the FDA, the EU's safety committee, and the international fragrance association on current toxicology review. Whether you find that reassuring depends on how you weight animal data against equivocal human data. The review literature has not converged Kazemi et al. 2022.
"Perfume lasts forever." Sealed and stored away from light and heat, three to five years. Opened, one to three. Past that, the citrus turns vinegary, the florals go sour, and the allergen load quietly climbs.
What it actually costs and how to shop
A bottle is usually a one-to-three-year purchase. Designer EDT at $40–90 per 100 ml works out to under $30 a year at a daily spritz; mass-market eau de cologne is half that; niche houses with $200–400 bottles still come in under $200 a year amortised. The per-day cost is trivial; the upstream cost is finding something you actually like, which usually means burning through sample sets and a couple of full-bottle mistakes.
Sample before you commit. Almost every department store will spray a card or a wrist; most niche brands sell sample vials directly. A new fragrance on your own skin smells different at three hours than at three minutes — the top-notes that sell the bottle are gone by lunchtime and the base-notes, which are what you'll actually live with, only emerge late. Don't buy on the first sniff.
Store the bottle upright, capped, in a drawer, away from windows. Heat and UV light both accelerate the same oxidation that turns the lovely citrus opener into something sharp and unpleasant. The bathroom shelf above a hot shower is the worst place for a bottle. A bedroom drawer is fine.
Newer labels in the EU will list a longer string of allergen names — the regulator expanded the disclosure list from 24 substances to over 80, with the new labels mandatory on new products by 31 July 2026 European Commission 2023. If you've had reactions before, that label is genuinely useful; if you haven't, it isn't a reason to panic.
Related
Most of fragrance's "smell good" return is actually built earlier in the day, by hygiene — a good shower, a fresh shirt, an antiperspirant that works for your body chemistry. Perfume sits on top of that, not in place of it. Worth reading alongside this: deodorant and antiperspirant; oral hygiene and breath; laundry detergent and the soft baseline of "clean clothes" smell; and on the other side of the question, fragrance-free skincare and contact-allergen avoidance for the readers who turned out to be in the 5–10% with a sensitivity.
- — Antiperspirants are one of the daily products where added fragrance can irritate.
- — Perfume is the deliberate version; the same allergen risk hides unlabelled in everyday products too.
- — What makes your cologne last is often a phthalate; the 'phthalate-free' versions skip it.
- — Fragrance sits alongside posture, gaze, and smile as a low-cost lever on how strangers respond to you.
Substance + claimed effects
Fragrance — eaux de toilette (EDT, 5–15% aromatic compounds in ethanol), eau de parfum (EDP, 15–20%), parfum / extrait (20–40%), eau de cologne (EDC, 2–5%) — is a personal-care product applied to skin or clothing whose stated function is olfactory. The category's meaningful consequences for an entry: (i) social perception of the wearer by others, (ii) self-perception and mood of the wearer, (iii) systemic and topical exposure to solvents, fixatives (phthalates, primarily diethyl phthalate / DEP), and fragrance allergens (limonene, linalool, hydroxycitronellal, eugenol, etc.), (iv) projection and longevity as a function of concentration and application, and (v) externalised effects on bystanders — fragrance-triggered headache, asthma, and contact dermatitis in roughly 30% of populations sampled. The entry covers all five holistically.
Evidence by addressing question
mechanism
Fragrance acts through three coupled pathways. Volatilisation from skin — alcohol solvent flashes off in seconds carrying volatile top-notes (citrus aldehydes, light terpenes), mid-notes (florals) follow over minutes, base-notes (musks, woods, resins, ambergris analogues) bind to skin lipids and release over hours. Higher oil concentration extends base-note residence; higher alcohol fraction (EDT, EDC) accelerates top-note flash. Olfactory uptake by the perceiver — odorants bind G-protein-coupled olfactory receptors in the nasal epithelium and project via the olfactory bulb directly to piriform cortex, amygdala, and entorhinal cortex without thalamic relay. This is the anatomical basis for the documented privileged coupling between odor and emotional memory and mood — odors recruit affective circuitry before they recruit semantic processing. Self-perception loop in the wearer — applying a fragrance and smelling oneself modulates self-confidence and nonverbal behaviour, which in turn alters how others read the wearer even on cues that don't include the odour itself (Roberts et al. 2009 showed deodorant-arm men were rated more attractive from silent video by women who could not smell them).
evidence
Social perception. Roberts et al. (2009): a randomised controlled trial assigned 35 men to a fragranced antiperspirant arm or an alcohol-only placebo arm for 48 hours. The fragranced group self-reported higher confidence and was rated significantly more attractive by female raters viewing 15-second silent video clips — raters had no olfactory exposure, so the effect propagated through behavioural change in the wearer (Roberts et al. 2009, doi:10.1111/j.1468-2494.2008.00477.x). Higuchi et al. (2005) replicated the silent-video design in Japanese female perfume-wearers and showed measurable improvement in observer-rated nonverbal behaviour after fragrance application. Davies-Owen et al. (2024) extended this in a within-subject neuroimaging-adjacent paradigm: pleasant fragrance boosted attractiveness, confidence, and femininity ratings of both self-faces and other-faces, with concomitant modulation of early visual ERPs — fragrance reaches face-processing cortex within ~200 ms (Davies-Owen et al. 2024).
Mood. Effects on subjective mood are small-to-moderate, condition-dependent, and dominated by associative learning rather than odorant pharmacology — the literature converges on a "scent + memory + expectation" model rather than direct psychoactive effect. The catalogue's meta should weight this conservatively.
Ingredient exposure. Kazemi et al. (2022) systematic review of 37 studies of perfume/cologne pollutants identifies phthalates (predominantly DEP), aldehydes, parabens, and aluminium salts as the most-frequently flagged contaminants; adverse outcomes named include contact allergy, reproductive effects (animal-model), nervous-system effects, and migraine. DEP is a low-molecular-weight phthalate used as a fragrance fixative; it is permitted by FDA, IFRA, and the EU SCCS as low-toxicity and remains the dominant detected phthalate in personal fragrance. Higher-concern phthalates (DEHP, DBP, BBP) are EU-restricted in cosmetics but have been detected above legal thresholds in spot-screening of branded perfumes (Kazemi et al. 2022; Alblooshi 2025). Alblooshi (2025) narrative review synthesises evidence linking parabens and certain phthalates to endocrine disruption with stronger animal evidence and equivocal human data, flagging cumulative and prenatal exposure as the higher-risk scenarios.
Allergens. Limonene and linalool are the two most-used fragrance ingredients in cosmetics (present in ~30% and ~26% of EU products respectively). They are themselves weak sensitisers, but on air exposure they oxidise to hydroperoxides which are potent contact sensitisers. Sukakul et al. (2022) patch-tested 5,773 consecutive dermatitis patients; 7.0% reacted to oxidised linalool, 5.1% to oxidised limonene, with significant increasing trends over the observation period (Sukakul et al. 2022, doi:10.1111/cod.13980). Population-prevalence of fragrance contact allergy in the general European population is estimated 1.1–2.6%, rising to ~15% in dermatitis cohorts. EU Regulation 2023/1545 expands the labelled-allergen list from 24 to 80+ substances; new products must comply by 31 July 2026.
Sensitivity in others. Steinemann (2019), pooled population surveys across US, AU, UK, SE (n≈4,400): 32.2% of adults report adverse health effects from exposure to fragranced products applied by others — respiratory difficulties (16.7%), mucosal symptoms (13.2%), migraine (12.6%), skin rash (9.1%), asthma attack (7.0%). 9.5% report potentially-disabling effects. 9.0% have lost workdays or a job in the preceding 12 months due to workplace fragrance exposure. Steinemann (2018), US asthmatic-cohort survey (n=1,137): 64.3% of asthmatics report ≥1 adverse health effect from fragranced products (POR 5.76, 95% CI 4.34–7.64 vs non-asthmatics), and 35.4% report fragrance-related workday or job loss. Silva-Néto et al. (2014), case-control of 200 migraineurs vs 200 tension-type controls: odour exposure triggered headache in 70.0% of migraineurs vs 0% of controls (specificity 100%, 95% CI 97.6–100); perfume was the dominant trigger at 75.7% of odour-triggered events, ahead of paint (42.1%) and gasoline (28.6%).
protocol
Application technique influences projection, longevity, and bystander exposure. Pulse points (wrists, neck, sternum, behind ears) sit over surface arteries at ~34–36 °C; the warmth volatilises top-notes faster than cooler skin, lifting initial projection at the cost of base-note longevity. Spray > dab: aerosolised mist distributes evenly across pulse-point area and binds to skin lipids; dabbing concentrates oil into a localised patch that over-saturates olfactory receptors at close range and depletes faster (industry consensus, no RCT evidence). Rubbing wrists together shears mid-note esters and is widely deprecated by perfumers. Pre-application moisturisation extends longevity on dry skin where fragrance otherwise dissipates faster. Standard load: 2–4 sprays distributed across pulse points for EDP; 4–6 for EDT (lower concentration). Hair holds fragrance well but ethanol is drying — preferred surface is clothing collar/scarf, which extends sillage by hours without skin contact.
contraindications
Documented bystander harm is the load-bearing contraindication, not wearer harm. (i) Confined shared spaces — open-plan offices, lifts, aircraft cabins, healthcare waiting rooms — concentrate volatilised fragrance to levels where the third of the population with fragrance sensitivity (Steinemann 2019) reports respiratory or migraine symptoms; the 7% asthmatic-attack rate in the four-country survey is the upper bound on real risk to bystanders. Fragrance-free policies in clinical and hospital settings are now common across Canada, Scandinavia, and parts of the US public sector. (ii) Personal contact-allergen risk rises with bottle age — opened fragrance oxidises limonene and linalool to their hydroperoxide forms within 1–3 years, multiplying allergen potency without any label change. Patients with confirmed fragrance contact allergy on patch testing should consider rotating bottles rather than keeping a single bottle for years. (iii) Pregnancy and infants — Alblooshi (2025) and Kazemi (2022) both flag cumulative phthalate burden during pregnancy as the most-studied higher-risk scenario; mainstream recommendation is moderation, not avoidance, given that DEP-specific human evidence remains equivocal.
misconceptions
(i) "Higher concentration = stronger projection." Inverse: higher oil concentration extends residence on skin but reduces volatilisation rate. Parfum projects less than EDT in the first 30 minutes and outlasts it past hour 6. (ii) "Hypoallergenic / natural fragrance = safe." Limonene and linalool are naturally occurring terpenes from citrus and lavender; oxidised hydroperoxides are the dominant fragrance sensitisers in the contemporary patch-test population (Sukakul 2022). "Natural" raises allergen risk relative to synthetic musks. (iii) "If you can smell yourself, it's projecting." Olfactory fatigue means the wearer adapts within minutes; perceived self-smell is a poor proxy for sillage. (iv) "DEP / phthalates in fragrance are banned in the EU." EU restricts DEHP, DBP, BBP and related CMR-classified phthalates; DEP — the dominant fragrance fixative — is permitted by IFRA, EU SCCS, FDA, and US EPA on current toxicology review. (v) "Old perfume lasts forever if it's sealed." Opened bottles oxidise; citrus turns turpentine-adjacent, florals turn vinegary, terpene hydroperoxides accumulate and skin-allergen potency rises.
practicalities
Cost ranges three orders of magnitude — niche house EDP 100 ml retails $200–$400; designer EDT 100 ml $40–$90; mass-market EDC $10–$25; per-application cost trivial relative to bottle cost. Bottle longevity 1–3 years opened, 3–5 sealed and stored away from light/heat — UV photodegradation and air oxidation both accumulate. Effort is near-zero once a wearer settles on a fragrance — sub-minute application; the upstream cost is discovery (sampling, mis-buys before finding a match). Workplace norms vary sharply by sector — healthcare, food service, many open-plan offices have explicit or implicit fragrance-free expectations.
alternatives
For social-signal goal: clean hygiene + good-fitting deodorant covers most of the documented attractiveness gain (Roberts et al. 2009 used antiperspirant, not perfume). Scented body wash and aftershave/deodorant in the same scent family achieve sillage comparable to EDC at lower per-application volatile load. For mood goal: ambient/at-home diffusion (incense, candles, room spray) achieves the scent-evoked-mood effect without the bystander exposure of wearable fragrance.
failure-modes
Common screwups: (i) over-spraying — wearer's olfactory fatigue masks projection that is socially excessive; rule-of-thumb is one spray less than the wearer thinks is right. (ii) wearing the same heavy base-note (oud, tobacco, leather) in confined work spaces — the Steinemann population is one in three; sillage that's a feature on a date is the failure mode on a Zoom-call commute. (iii) keeping a bottle for a decade — terpene hydroperoxide accumulation converts a low-risk product into a contact-allergen even for non-sensitised users.
audience
Population variability is large but not systematic by demographic. Women score higher on olfactory acuity and emotional response to ambient scent on most published designs, but social-perception effects on the wearer (Roberts 2009, Davies-Owen 2024) appear in both sexes. Migraineurs and confirmed-asthmatic populations are the largest identifiable at-risk subgroups for second-hand exposure. People with atopic dermatitis or known fragrance contact allergy on patch test are the at-risk subgroup for personal exposure.
The credibility range
Optimist case
Fragrance is one of a small set of low-effort interventions with a documented behavioural and social-perception effect. Roberts 2009 and Higuchi 2005 both isolate the effect through silent-video designs that strip the olfactory channel from the rater — what remains is mediated through wearer behaviour, which is a real, replicated finding. Davies-Owen 2024 extends this with within-subject neural correlates. The mood-and-confidence effect is small but reliable; cumulative effect over years of daily wear is non-trivial. Phthalate and allergen panic is disproportionate to the human evidence: the dominant fixative (DEP) has been re-evaluated repeatedly and remains permitted; serious sensitiser risk is concentrated in oxidised old bottles, not the product as sold. Modern formulations are progressively safer (IFRA 51st Amendment; EU 2023/1545 expanded labelling).
Skeptic case
The social-perception effects are real but modest in effect size and rest on a small handful of studies, mostly from a single research group (Roberts and Havlicek). Mood effects are dominated by associative conditioning and expectation — the active pharmacology is thin. Meanwhile the bystander cost is substantial and well-documented: ~30% of the population reports adverse health effects from second-hand fragrance exposure, ~7% have asthma attacks triggered, 70% of migraineurs are triggered by odour with perfume the dominant trigger, and 9% lose workdays or jobs annually. Personal allergen risk rises sharply with bottle age, and EU regulators expanded the declared-allergen list from 24 to 80+ because the prior list was inadequate. The honest framing is that fragrance is a positive-externality-for-wearer, negative-externality-for-others product whose social-perception upside is purchased at a small public-health cost the wearer doesn't pay.
Author's call
Both cases are correct as stated. The wearer-side upside is real and replicated; the bystander-side cost is real and population-scale. The catalogue should land on "use deliberately, modestly, and not in confined shared spaces" — a know-how entry, not an avoid entry and not a do-this-daily entry. Meta scores reflect: modest direct beauty/social effect (beauty_direct 2), modest mood effect (mood 1), low effort, low-to-modest cost, evidence solid on social perception but mixed on health, controversy moderate because the fragrance-sensitivity literature is contested by the industry.
Stakeholder + incentive map
- Industry (IFRA, RIFM, fragrance houses, brand owners). Multi-billion-dollar market; commercial incentive to maintain DEP permission, contest fragrance-sensitivity prevalence data, and frame allergen-labelling expansions as adequate consumer protection without product reformulation.
- EU regulators (SCCS, ECHA). Precautionary stance — expanded 2023 allergen list, REACH restrictions on CMR phthalates, ongoing Omnibus chemicals review. US regulators (FDA) lighter touch; cosmetics regulation broadly less restrictive.
- Dermatology / occupational medicine. Patch-test contact-dermatitis literature (Sukakul, the IVDK network) and the Steinemann fragrance-sensitivity research are the two main academic camps; both report rising effect sizes.
- Fragrance-free advocacy. Patient-organisation-led in Canada, Scandinavia, parts of US public sector; pushes workplace and healthcare policy.
- Hobbyist / collector community. Reddit r/fragrance, Basenotes, Fragrantica: large lay-evidence base on application technique, longevity per fragrance, bottle aging — consistent with industry consensus on application and storage.
Population variability
- Olfactory sensitivity — women > men on detection and identification; declines with age; migraineurs (95% report increased olfactory acuity ictally) and atopic individuals are hypersensitive.
- Skin chemistry — dry skin loses base-notes faster; oily skin holds longer. Skin pH and microbiome interaction with fragrance components is real but under-studied.
- Asthmatic and MCS populations — 12.8% of population report medically-diagnosed MCS; 7–28% of asthmatics report fragrance-triggered attacks depending on cohort.
- Pregnancy / infants — phthalate metabolite levels track cosmetic/PCP use; the precautionary-principle population.
Knowledge gaps
Independent, non-industry replication of the social-perception effect is thin; the published literature is dominated by a small set of groups (Roberts/Havlicek; Shiseido/Higuchi). The dose-response curve for projection vs concentration is industry-internal and not transparently published. Long-term cumulative phthalate exposure in humans through cosmetics is observational and confounded by polyexposure. Mechanistic studies on whether IFRA's progressive restriction of confirmed allergens is moving population sensitisation rates downward are absent — Sukakul et al. show rising prevalence over the observation window despite tightening regulation, which is unexplained.
Scoping calls. Brief named five consequences — social perception, mood, ingredient exposure, projection/longevity, sensitivity in others. All five are covered in the body. The article's centre of gravity is the wearer/bystander asymmetry (positive externality for the wearer, negative externality for ~30% of the people around them), which is the framing that best resolves the brief's spread.
Action and cadence. Set to know + daily rather than do + daily. The catalogue's house position is that fragrance is a deliberate-use product with non-trivial bystander cost, not a daily-recommend. The article body still gives an action callout under protocol for readers who do choose to wear it.
Rating difficulty: beauty_direct. Scored 2 (real but small). The silent-video literature (Roberts 2009, Higuchi 2005, Davies-Owen 2024) is replicated but small, dominated by a narrow set of research groups, and the effect sizes are nudges rather than transformations. A 3 felt over-claimed for a non-cosmetic-procedure intervention.
Rating difficulty: mood. Scored 1, not 2. The literature on direct mood effects of fragrance is dominated by associative conditioning and demand characteristics; nothing in the dossier supports a "real but small daily improvement in how you feel."
Phthalates framing. Held the line on equivocal human evidence for DEP specifically rather than the precautionary frame favoured in some recent narrative reviews. The brief named "ingredient exposure" without prejudging the call; the article reports both the regulator-permitted status and the active toxicology debate.
Excluded. Aromatherapy and essential-oil therapeutics — different substance, different evidence base, warrants its own entry. Pheromone and androstadienone literature — too speculative, too contested, would dilute the dossier. Workplace fragrance-free policy mechanics — policy material rather than personal handbook.
Future-link candidates. Deodorant and antiperspirant; contact dermatitis and patch testing; phthalates / endocrine disruptors as a cross-cutting environmental-exposure entry; migraine triggers.
Separate-entry candidates. Aromatherapy / essential oils; ambient scent and indoor-air environment design.
Fragrance
Designer EDT/EDP runs $40–200 per 100 ml lasting 1–3 years opened; per-day cost is trivial. Niche/luxury houses can push annual cost into the $200–500 range but most wearers stay well below $50/year amortised.
Sub-minute application step; the only real effort is upstream discovery (sampling, mis-buys before finding a match). Zero ongoing willpower.
Social-perception effect replicated across silent-video designs (Roberts 2009, Higuchi 2005, Davies-Owen 2024); bystander-effect prevalence well-quantified (Steinemann 2018, 2019; Silva-Néto 2014). Mood-effect literature thinner. No large RCTs, no Cochrane-level meta-analyses.
Documented social-perception lift mediated through wearer self-confidence and nonverbal behaviour (Roberts et al. 2009 silent-video RCT; Higuchi et al. 2005; Davies-Owen et al. 2024) — real but modest in effect size and not a transformative cosmetic effect.
Scent-emotion coupling via direct olfactory projection to amygdala/entorhinal cortex produces a small, conditioning-driven mood lift on application; effect is real but dominated by associative learning rather than odorant pharmacology.